(Q33846455)

29 July 2017

1 reference

title

Synthetic surfactants to treat neonatal lung disease (English)

1 reference

29 July 2017

0 references

2

Johansson J

1 reference

29 July 2017

Robertson B

1

1 reference

29 July 2017

Curstedt T

series ordinal

3

1 reference

29 July 2017

publication date

1 March 2000

1 reference

Trends in Molecular Medicine

29 July 2017

published in

1 reference

29 July 2017

volume

6

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

119-124

1 reference

Surface activity of lipid extract surfactant in relation to film area compression and collapse

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Molecular structures and interactions of pulmonary surfactant components

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Interfacial properties of surfactant proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Saposin fold revealed by the NMR structure of NK-lysin

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Structure and properties of surfactant protein C

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Structure and orientation of lung surfactant SP-C and L-alpha-dipalmitoylphosphatidylcholine in aqueous monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

The pulmonary surfactant protein C (SP-C) precursor is a type II transmembrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Phase and morphology changes in lipid monolayers induced by SP-B protein and its amino-terminal peptide

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

The 21-residue surfactant peptide (LysLeu4)4Lys(KL4) is a transmembrane alpha-helix with a mixed nonpolar/polar surface

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Exogenous surfactants in a piglet model of acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Bronchoalveolar lavage with KL4-surfactant in models of meconium aspiration syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

The surface properties of chemically synthesized peptides analogous to human pulmonary surfactant protein SP-C.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Secondary structure and biophysical activity of synthetic analogues of the pulmonary surfactant polypeptide SP-C

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Synthetic peptide-containing surfactants--evaluation of transmembrane versus amphipathic helices and surfactant protein C poly-valyl to poly-leucyl substitution.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Characterization of poly-leucine substituted analogues of the human surfactant protein SP-C

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Effects of lung surfactant factor (LSF) treatment on gas exchange and histopathological changes in an animal model of adult respiratory distress syndrome (ARDS): comparison of recombinant LSF with bovine LSF

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Dose‐response comparisons of five lung surfactant factor (LSF) preparations in an animal model of adult respiratory distress syndrome (ARDS)

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Effects of rSP-C surfactant on oxygenation and histology in a rat-lung-lavage model of acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Comparison of rSP-C surfactant with natural and synthetic surfactants after late treatment in a rat model of the acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

New targets for surfactant replacement therapy: experimental and clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901656-1

7 January 2021

10.1016/S1357-4310(99)01656-1

Identifiers

DOI

1 reference

29 July 2017

1 reference